Facilities

DSM and Crucell celebrate opening of PERCIVIA PER.C6 Development Center

Published in Health Business Week, December 15th, 2006

Dutch biotechnology company Crucell N.V. (CRXL; CRX) and technology partner DSM Biologics, a business unit of DSM Pharmaceutical Products, announced the opening of the PERCIVIA PER.C6 Development Center in Cambridge, Massachusetts, a product of an earlier announced joint venture between the two Dutch companies.

PERCIVIA was conceived and designed to further develop the PER.C6 cell line and provide turnkey solutions for the production of pharmaceutical proteins to licensees utilizing the PER.C6 human cell line in the biotech industry - currently a US$35 billion industry.

"PERCIVIA's state-of-the-art facility will generate the know-how and support for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2006-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry